Goodwin Procter advised Pardes Biosciences, while White & Case advised FS Development Corp. II on the deal.FS Development Corp. II (Nasdaq: FSII), a special purpose acquisition…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
